NPPA Remdesivir Pricing

Price of Remdesivir injection reduced after govt’s intervention

Due to Government’s intervention, the price of Remdesivir Injection is now reduced.

National Pharmaceutical Pricing Authority in an office memorandum said, major Pharma companies have announced voluntary price cuts for Remdesivir Injections after Centre’s intervention to ensure it’s affordable availability.

Cadila Healthcare’s Remdac will now cost Rs. 899 instead of Rs. 2,800.

Syngene International’s RemWin will now cost Rs. 2,450 instead of Rs. 3,950.

Dr Reddy’s Redyx will be available at Rs. 2, 700 instead of Rs. 5,400.

Cipla’s Cipremi will cost Rs. 3,000 instead of Rs. 4000.

Mylan Pharmaceutical’s Desrem will be available at Rs. 3,400 instead of Rs. 4,800.

Jubilant Generic’s Jubi-R will now cost Rs. 3,400 instead of Rs. 4,700.

Hetero Healthcare’s Covifor will be available at Rs. 3490 instead of Rs. 5,400.

Published by Naresh Sagar

Mentor MSME, Motivator, Media Event Org, Management fiscal & Water management.Social Media branding,Internet broadcasters,Propunder of Indian Philosophy

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: